Recent Publications

  1. Zhang, X., Branciamore, S., Gogoshin, G., Rodin, A.S., & Riggs, A.D. (2017). Analysis of high-resolution 3D intrachromosomal interactions aided by Bayesian network modeling. Proceedings of the National Academy of Sciences of the United States of America, 114(48), E10359-E68. https://doi.org/10.1073/pnas.1620425114
  2. Eng, O.S., Dumitra, S., O'Leary, M., Raoof, M., Wakabayashi, M., Dellinger, T.H., Han, E.S., Lee, S.J., Paz, I.B., & Lee, B. (2017). Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. JAMA Surg, 152(12), 1156-60. https://doi.org/10.1001/jamasurg.2017.2865
  3. Zeng, D.F. (2017). Bridge between type 1 diabetes in mouse and man. Proceedings of the National Academy of Sciences of the United States of America, 114(41), 10821-3. https://doi.org/10.1073/pnas.1715058114
  4. Mirzaei, H.R., Rodriguez, A., Shepphird, J., Brown, C.E., & Badie, B. (2017). Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications. Front Immunol, 8(DEC), 1850. https://doi.org/10.3389/fimmu.2017.01850
  5. Lin, C.H., Jokela, T., Gray, J., & LaBarge, M.A. (2017). Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound. Cell Reports, 21(2), 533-45. https://doi.org/10.1016/j.celrep.2017.09.058
  6. Yuan, Y., Kos, F.J., He, T.F., Yin, H.H., Li, M., Hardwick, N., Zurcher, K., Schmolze, D., Lee, P., Pillai, R.K., Chung, V., & Diamond, D.J. (2017). Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab. Oncoimmunology, 6(12). https://doi.org/10.1080/2162402X.2017.1363138
  7. Jandial, R. (2017). Curing brain metastases. Clinical and Experimental Metastasis, 34(6-7), 363-4. https://doi.org/10.1007/s10585-017-9866-6
  8. Nelson, R.A., & Lai, L.L. (2017). Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Cancer, 123(20), 4013-21. https://doi.org/10.1002/cncr.30828
  9. Pal, S.K., Sonpavde, G., Agarwal, N., Vogelzang, N.J., Srinivas, S., Haas, N.B., Signoretti, S., McGregor, B.A., Jones, J., Lanman, R.B., Banks, K.C., & Choueiri, T.K. (2017). Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma. European Urology, 72(4), 557-64. https://doi.org/10.1016/j.eururo.2017.03.046
  10. Deng, R., Hurtz, C., Song, Q., Yue, C., Xiao, G., Yu, H., Wu, X., Muschen, M., Forman, S., Martin, P.J., & Zeng, D. (2017). Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease. Nature Communications, 8(1). https://doi.org/10.1038/s41467-017-00880-2
  11. Aldoss, I., Pham, A., Li, S.M., Gendzekhadze, K., Afkhami, M., Telatar, M., Hong, H., Padeganeh, A., Bedell, V., Cao, T., Khaled, S.K., Al Malki, M.M., Salhotra, A., Ali, H., Aribi, A., Palmer, J., Aoun, P., Spielberger, R., Stein, A.S., Snyder, D., O’Donnell, M.R., Murata-Collins, J., Senitzer, D., Weisenburger, D., Forman, S.J., Pullarkat, V., Marcucci, G., Pillai, R., & Nakamura, R. (2017). Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status. Haematologica, 102(12), 2030-8. https://doi.org/10.3324/haematol.2017.172544
  12. Tran, T.Q., Ishak Gabra, M.B., Lowman, X.H., Yang, Y., Reid, M.A., Pan, M., O'Connor, T.R., & Kong, M. (2017). Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes. PLoS Biology, 15(11), e2002810. https://doi.org/10.1371/journal.pbio.2002810
  13. Hua, W.K., Qi, J., Cai, Q., Carnahan, E., Ayala Ramirez, M., Li, L., Marcucci, G., & Kuo, Y.H. (2017). HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity. Blood, 130(24), 2619-30. https://doi.org/10.1182/blood-2017-03-771386
  14. Kusmartseva, I., Beery, M., Philips, T., Selman, S., Jadhav, P., Wasserfall, C., Muller, A., Pugliese, A., Longmate, J.A., Schatz, D.A., Atkinson, M.A., & Kaddis, J.S. (2017). Hospital time prior to death and pancreas histopathology: implications for future studies. Diabetologia, Epub ahead of print. https://doi.org/10.1007/s00125-017-4494-x
  15. Alvarnas, J.C., Zaia, J.A., & Forman, S.J. (2017). How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation. Blood, 130(18), 1976-84. https://doi.org/10.1182/blood-2017-04-551606
  16. Herrera, A.F., & Armand, P. (2017). Mini mal Residual Disease Assessment in Lymphoma: Methods and Applications. Journal of Clinical Oncology, 35(34), 3877-87. https://doi.org/10.1200/jco.2017.74.5281
  17. Cho, M., Gong, J., Frankel, P., Synold, T.W., Lim, D., Chung, V., Chao, J., Li, D.N., Chen, Y., Sentovich, S., Melstrom, K., Singh, G., Luevanosi, E., & Fakih, M. (2017). A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy. Oncotarget, 8(45), 79750-60. https://doi.org/10.18632/oncotarget.19336
  18. Weisenburger, D.D., & Gross, T.G. (2017). Post-transplant lymphoproliferative disorder: a heterogeneous conundrum. British Journal of Haematology, 179(5), 854-6. https://doi.org/10.1111/bjh.14274
  19. Onyango, D.O., Lee, G., & Stark, J.M. (2017). PRPF8 is important for BRCA1-mediated homologous recombination. Oncotarget, 8(55), 93319-37. https://doi.org/10.18632/oncotarget.21555
  20. Das, S., Senapati, P., Chen, Z., Reddy, M.A., Ganguly, R., Lanting, L., Mandi, V., Bansal, A., Leung, A., Zhang, S., Jia, Y., Wu, X., Schones, D.E., & Natarajan, R. (2017). Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells. Nature Communications, 8(1). https://doi.org/10.1038/s41467-017-01629-7
  21. van Megen, K.M., Spindler, M.P., Keij, F.M., Bosch, I., Sprangers, F., van Royen-Kerkhof, A., Nikolic, T., & Roep, B.O. (2017). Relapsing/remitting type 1 diabetes. Diabetologia, 60(11), 2252-5. https://doi.org/10.1007/s00125-017-4403-3
  22. Johnsson, P., Lister, N., Shevchenko, G., Walshe, J., Ataide, S.F., & Morris, K.V. (2017). Reply to Liu et al.: Yin and yang of PTEN regulation. Proceedings of the National Academy of Sciences of the United States of America, 114(49), E10512-E3. https://doi.org/10.1073/pnas.1718258114
  23. Bergerot, P., Agarwal, N., Pal, S.K., & Jones, J. (2017). Sarcomatoid renal cell carcinoma: The apple doesn't fall far from the tree. Clinical Cancer Research, 23(21), 6381-3. https://doi.org/10.1158/1078-0432.CCR-17-2039
  24. Lifshitz, V., Priceman, S.J., Li, W., Cherryholmes, G., Lee, H., Makovski-Silverstein, A., Borriello, L., DeClerck, Y.A., & Yu, H. (2017). Sphingosine-1-phosphate receptor-1 promotes environment-mediated and acquired chemoresistance. Molecular Cancer Therapeutics, 16(11), 2516-27. https://doi.org/10.1158/1535-7163.MCT-17-0379
  25. Jiang, X., Hu, C., Ferchen, K., Nie, J., Cui, X., Chen, C.H., Cheng, L., Zuo, Z., Seibel, W., He, C., Tang, Y., Skibbe, J.R., Wunderlich, M., Reinhold, W.C., Dong, L., Shen, C., Arnovitz, S., Ulrich, B., Lu, J., Weng, H., Su, R., Huang, H., Wang, Y., Li, C., Qin, X., Mulloy, J., Zheng, Y., Diao, J., Jin, J., Li, C., Liu, P.P., He, C., Chen, Y., & Chen, J. (2017). Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia. Nature Communications, 8(1). https://doi.org/10.1038/s41467-017-02290-w
  26. Suwandi, J.S., Nikolic, T., & Roep, B.O. (2017). Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials. Front Immunol, 8(NOV), 1598. https://doi.org/10.3389/fimmu.2017.01598
  27. He, Z., Ma, J., Wang, R., Zhang, J., Huang, Z., Wang, F., Sen, S., Rothenberg, E.V., & Sun, Z. (2017). A two-amino-acid substitution in the transcription factor RORgammat disrupts its function in TH17 differentiation but not in thymocyte development. Nature Immunology, 18(10), 1128-38. https://doi.org/10.1038/ni.3832